Related Experiment Videos
[Percutaneous transluminal coronary angioplasty]
M Pfisterer1, W Kiowski, H E Schmitt
1Departement Innere Medizin, Universitätskliniken, Kantonsspital Basel.
Therapeutische Umschau. Revue Therapeutique
|August 1, 1991
Summary
Percutaneous Transluminal Coronary Angioplasty (PTCA) has evolved significantly, expanding indications and improving success rates while reducing complications. Restenosis remains a key challenge requiring ongoing patient follow-up.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Percutaneous Transluminal Coronary Angioplasty (PTCA) has a history of evolution.
- Indications for PTCA have expanded due to experience and technological advancements.
Purpose of the Study:
- To demonstrate the evolution of PTCA based on clinical experience and data.
- To highlight improvements in PTCA success rates and complication reduction.
Main Methods:
- Analysis of PTCA outcomes from Basel experience.
- Review of PTCA data from Switzerland.
Main Results:
- PTCA indications have markedly extended.
- Primary success rates have risen, and severe complication rates have dropped.
- Despite advancements, restenosis remains an unsolved problem.
Conclusions:
- PTCA has evolved into a safer and more effective procedure.
- Restenosis is a persistent challenge necessitating vigilant follow-up for patients undergoing PTCA.